ZA899450B - Topical formulations and transdermal delivery systems containing 1-isobutyl-1h-imidazo(4,5-c)quinolin-4-amine - Google Patents

Topical formulations and transdermal delivery systems containing 1-isobutyl-1h-imidazo(4,5-c)quinolin-4-amine

Info

Publication number
ZA899450B
ZA899450B ZA899450A ZA899450A ZA899450B ZA 899450 B ZA899450 B ZA 899450B ZA 899450 A ZA899450 A ZA 899450A ZA 899450 A ZA899450 A ZA 899450A ZA 899450 B ZA899450 B ZA 899450B
Authority
ZA
South Africa
Prior art keywords
quinolin
imidazo
isobutyl
amine
delivery systems
Prior art date
Application number
ZA899450A
Other languages
English (en)
Inventor
Steven Marshall Wick
Marshall Wick Steven
Helen Jensen Schultz
Jensen Schultz Helen
Gregory Roy Nelson
Roy Nelson Gregory
Amit Kumar Mitra
Kumar Mitra Amit
Stephen Michael Berge
Michael Berge Stephen
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of ZA899450B publication Critical patent/ZA899450B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA899450A 1988-12-15 1989-12-11 Topical formulations and transdermal delivery systems containing 1-isobutyl-1h-imidazo(4,5-c)quinolin-4-amine ZA899450B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28493388A 1988-12-15 1988-12-15

Publications (1)

Publication Number Publication Date
ZA899450B true ZA899450B (en) 1990-09-26

Family

ID=23092090

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA899450A ZA899450B (en) 1988-12-15 1989-12-11 Topical formulations and transdermal delivery systems containing 1-isobutyl-1h-imidazo(4,5-c)quinolin-4-amine

Country Status (14)

Country Link
EP (1) EP0376534B1 (xx)
JP (1) JP2915034B2 (xx)
KR (1) KR0150445B1 (xx)
AU (1) AU631585B2 (xx)
CA (1) CA2004597C (xx)
DE (2) DE68911499T2 (xx)
DK (1) DK176121B1 (xx)
ES (1) ES2062043T3 (xx)
HK (1) HK1006275A1 (xx)
IE (1) IE62569B1 (xx)
IL (1) IL92537A (xx)
NL (1) NL980042I1 (xx)
NZ (1) NZ231655A (xx)
ZA (1) ZA899450B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232740A (en) * 1989-04-20 1992-06-25 Riker Laboratories Inc Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
KR960703621A (ko) * 1993-08-10 1996-08-31 후지야마 아키라 경피흡수 제제(Percutaneously absorbable preparation)
DE4434775A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Dermatologische Zubereitungen mit einem Gehalt an Fettsäureglyceriden gegen Superinfektionen
US5939090A (en) * 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
IT1294748B1 (it) 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
NZ512628A (en) * 1999-01-08 2004-03-26 3M Innovative Properties Co Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
WO2002092070A1 (en) * 2001-05-11 2002-11-21 Elan Corporation, Plc Isostearic acid salts as permeation enhancers
EP1390383B1 (en) 2001-05-11 2012-02-29 Isis Pharmaceuticals, Inc. Antisense permeation enhancers
CN1292751C (zh) * 2002-04-23 2007-01-03 四川大学 皮肤局部用咪喹莫特或其衍生物脂质体及其制备方法和用途
CN100558361C (zh) 2003-03-13 2009-11-11 3M创新有限公司 改善皮肤质量的方法
EP2526950A1 (en) 2006-04-07 2012-11-28 Merrion Research III Limited Solid oral dosage form containing an enhancer
US9023863B2 (en) 2006-07-14 2015-05-05 Stiefel Research Australia Pty Ltd Fatty acid pharmaceutical foam
EP1889609B1 (en) * 2006-07-18 2019-05-22 Meda AB Immune response modifier foam formulations
KR20110007614A (ko) 2008-05-07 2011-01-24 메리온 리서치 Ⅲ 리미티드 ＧｎＲＨ 관련 화합물의 조성물 및 제조 방법
WO2011120033A1 (en) 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
CN103476419A (zh) 2011-01-07 2013-12-25 梅里翁第三研究有限公司 口服投药的含铁药物组合物
EP3250191B1 (en) 2015-01-29 2024-01-17 Novo Nordisk A/S Tablets comprising glp-1 agonist and enteric coating
ES2940736B2 (es) 2021-11-09 2023-09-19 Ntd Labs S L U Uso combinado de imiquimod y de un hidrolizado de caseina para el tratamiento de condilomas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
CA1272445A (en) * 1985-02-25 1990-08-07 Yie W. Chien Transdermal pharmaceutical absorption dosage unit and process of pharmaceutical administration
CA1288698C (en) * 1985-08-30 1991-09-10 Yie W. Chien Transdermal anti-anginal pharmaceutical dosage

Also Published As

Publication number Publication date
ES2062043T3 (es) 1994-12-16
JP2915034B2 (ja) 1999-07-05
KR900009084A (ko) 1990-07-02
KR0150445B1 (ko) 1998-10-15
CA2004597A1 (en) 1990-06-15
IE62569B1 (en) 1995-02-08
DE68911499D1 (de) 1994-01-27
IL92537A0 (en) 1990-08-31
AU4670689A (en) 1990-06-21
HK1006275A1 (en) 1999-02-19
AU631585B2 (en) 1992-12-03
CA2004597C (en) 2000-02-08
DE19975026I2 (de) 2010-07-08
IE893888L (en) 1990-06-15
DK613889A (da) 1990-06-16
IL92537A (en) 1994-04-12
DE68911499T2 (de) 1994-06-30
JPH02282327A (ja) 1990-11-19
DK613889D0 (da) 1989-12-06
EP0376534A1 (en) 1990-07-04
DK176121B1 (da) 2006-09-11
NZ231655A (en) 1992-06-25
EP0376534B1 (en) 1993-12-15
NL980042I1 (nl) 1999-02-01

Similar Documents

Publication Publication Date Title
ZA899450B (en) Topical formulations and transdermal delivery systems containing 1-isobutyl-1h-imidazo(4,5-c)quinolin-4-amine
EG18104A (en) Imidazoquinoline antithrombogenic cardiotonic agent
AU5005490A (en) 1h-imidazo(4,5-c)quinolin-4-amines
IL87135A0 (en) Estradiol transdermal delivery system
AU5149690A (en) Parenteral formulation of 1-isobutyl-1H-imidazo (4,5-c) quinolin-4-amine
ZA894308B (en) Topical delivery system
HUP0000568A3 (en) Gel formulations for topical drug delivery containing 4-amino-2-ethoxymethyl-alpha, alpha-dimethyl-1h-imidazo[4,5-c]quinoline-1-ethanol
AU7378987A (en) Drug delivery device, its preparation and use
GR861350B (en) Delivery system for active ingredients and preparation thereof
AU6216986A (en) Climbers wedging device
EP0198456A3 (en) 1,7-naphthyridine derivatives and medicinal preparations containing same
ZA898201B (en) Gestodene-containing agent for transdermal administration
AU5848386A (en) Agent delivery systems
IL96589A0 (en) 2-substituted-imidazo-(4,5-c)pyridines,their preparation,and pharmaceutical compositions containing them
IL78538A (en) (-)-1beta-ethyl-1alpha-hydroxymethyl-1,2,3,4,6,7,12,12balpha-octahydroindolo-(2,3-a)quinolizine,its preparation and pharmaceutical compositions containing it
AU5125390A (en) Substituted (quinolin-2-yl-methoxy)phenyl-n,n'- sulphonylureas, processes for their preparation and their use in medicaments
AU3800789A (en) Novel selenious acid-platinum complex and anti-tumor agent comprising said complex as effective ingredient
ZA863029B (en) Imidazoquinoline antithrombogenic cardiotonic agents
NZ215881A (en) Quinolizine derivatives and pharmaceutical compositions
ZA883894B (en) Pyrazolopyridine compound and processes for preparation thereof
AU7487887A (en) Protective devices for canulas
AU3913695A (en) Transdermal delivery device
GB8906081D0 (en) Oxygen administration systems
IE851799L (en) Quinolyl and 1,8-naphthyridine derivatives
AU2938289A (en) Imidazo- and pyrimido-quinoline, naphthyridine and pyridopyrazine compounds